Physician profile
Eric J Zimmer
NPI 1760494991
$1,727.45
in general payments reported to CMS, 2019-2025
10 companies · $260 in 2025
The $260 reported for 2025 was more than what 85% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.30 · 2020: $1,263 · 2022: $28.93 · 2024: $122 · 2025: $260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $382.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acelrx Pharmaceuticals, INC. | $1,250.00 | 2020 | |
| Alexion Pharmaceuticals, INC. | $130.41 | 2025 | Ultomiris |
| Pacira Pharmaceuticals Incorporated | $121.84 | 2024 | Exparel |
| Integra Lifesciences Corporation | $95.53 | 2025 | Integra, Surgimend, Omnigraft |
| Merck Sharp & Dohme LLC | $34.31 | 2025 | Bridion |
| Polynovo North America LLC | $28.93 | 2022 | |
| Merz North America, INC. | $27.50 | 2019 | |
| Duchesnay USA Incorporated | $14.44 | 2019 | |
| Emd Serono, INC. | $13.13 | 2020 | |
| Ferring Pharmaceuticals INC. | $11.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Zimmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.